The ability of proteins to self--assemble into different types of fibrils with distinct morphologies has been linked to the pathological and clinical heterogeneity of amyloid diseases such as Alzheimer's and Parkinson's disease. Herein, we describe novel nanoparticles (NPs) that efficiently label amyloid fibrils produced in vitro or isolated from postmortem tissues, under hydrating conditions and in such a way to unmask their polymorphism and morphological features. Using these NPs, we show that pathological aggregates exhibit exceptional morphological homogeneity compared to amyloid fibrils produced in vitro, consistent with the emerging view that the physiologic milieu is a key determinant of amyloid fibril strains. These advances pave the way for elucidating the structural basis of amyloid strains and toxicity.
3 exceptional homogeneity across the fibrils derived from human tissue in comparison to fibrils aggregated in vitro. The use of these NPs enabled us to gain novel insight into the structural features that distinguish amyloid fibrils formed in vivo from those formed in cell--free in vitro systems. Our findings demonstrate that these NPs represent a powerful tool for rapid imaging and profiling of amyloid morphological polymorphism in different types of samples, including those derived from complex biological aggregates found in human tissue and animal models of amyloid diseases. These advances should not only facilitate the profiling and characterization of amyloids for structural studies by cryo--EM but also pave the way to elucidate the structural basis of amyloid strains and toxicity and possibly the correlation between the pathological and clinical heterogeneity of amyloid diseases. 4 Amyloids are insoluble β--sheet--rich fibrillar protein aggregates found in pathological deposits and inclusions that characterize several neurodegenerative and systemic diseases (1) . These diseases span from degenerative diseases of the central nervous system, such as Alzheimer's disease (AD) and Parkinson's disease (PD), to systemic disorders, such as type II diabetes and systemic amyloidosis (1) (2) (3) (4) (5) . Although the mechanisms of amyloid formation in vivo and the nature of the toxic species remain subjects of intense investigation and debate, there is converging evidence that the fibrillization process plays a central role in neurodegeneration and pathology spreading in neurodegenerative diseases. Therefore, the prevention or inhibition of protein misfolding, aggregation and pathology spreading remains the most actively pursued goal to develop therapeutic strategies against amyloid diseases.
Increasing evidence from in vitro and animal models as well as structural studies on both ex vivo and synthetic aggregates have shown that amyloid--forming proteins can self--assemble into fibrils of distinct morphologies and toxic properties. Several studies have shown that amyloidogenic proteins such as amyloid--β (Aβ), α--synuclein and tau protein self--assemble in vitro into fibrils of different morphologies, e.g., ribbon, helical and straight fibrils, depending on their growth conditions (6) (7) (8) (9) (10) . Even in the same sample, different types of fibril morphologies have been shown to form and coexist, suggesting that they are either in an equilibrium or are derived from morphologically distinct intermediates on the pathway to aggregation (11, 12) . The polymorphism of cross-β fibrils has also been observed in ex vivo fibrils, for instance isolated tau fibrils from the brain of patients with AD (13) or amyloid fibrils from patients and animals with systemic amyloidosis of amyloid A (AA), transthyretin (ATTR) and light chain (AL) (14) .
Recent studies have demonstrated that introducing recombinant preformed fibrils or amyloid aggregates derived from diseased brains into neurons induces amyloid aggregation. The same process was observed when these fibrils were introduced directly to a specific region of the animal model brain. In these seeding--based models, distinct fibrillar polymorphs lead to different patterns of pathology spreading and/or toxicity (15) (16) (17) (18) . Tycko and coworkers have developed a method that enables the amplification of native amyloids by seeding monomeric Aβ with different fibril types isolated from different AD patients or brain regions (19, 20) . Their findings suggest a correlation between the amyloid fibril molecular structure, amyloid toxicity and symptomatology. Peng and colleagues (16) demonstrated that isolated cytoplasmic brain aggregates from Parkinson's disease (Lewy bodies, LBs) and multiple system atrophy (MSA; glial inclusions, GCIs) exhibit distinct conformations and drastically different seeding capacities of α--synuclein. GCI α--synuclein forms structures that are more compact and approximately a thousand--fold more potent than those of LB α--synuclein in terms of seeding capacity. Similar observations were made with tau (21) , where tau isolated from five different tauopathies was shown to indefinitely propagate distinct amyloid conformations in a clonal fashion when inoculated into a cellular model. These findings and the availability of cellular and animal models of amyloid propagation provide a unique opportunity to investigate the relationship between amyloid molecular and morphological polymorphism, neurodegeneration and pathology spreading in neurodegenerative diseases and are important for developing effective therapeutics. Nonetheless, it remains challenging to elucidate the structural basis and role of fibril polymorphism in human--derived material due to the minute amount of these aggregates and the complexity of the samples. Amyloid polymorphism can occur at different levels. Tycko and coworkers have established that the same protein can have different molecular arrangements when forming an amyloid fibril, and in this paper, we refer to this as molecular polymorphism (22) . Mezzenga and coworkers have shown that the shape, e.g., the symmetry and thickness of a fibril, varies depending on the number of protofilaments that compose the fibril (23) . We refer to this as morphological polymorphism. These two types of polymorphism are not mutually exclusive and could coexist.
Molecular polymorphism has been investigated using solid--state NMR (ssNMR) spectroscopy, microcrystallography and X--ray diffraction, while transmission electron microscopy (TEM), scanning probe microscopy and atomic force microscopy (AFM) have been used to investigate morphological polymorphism (24, 25) . These techniques have similar limitations: 1) they are time consuming; 2) they require large amounts of protein (e.g., ssNMR); 3) they can be applied only to small amyloid--forming peptides (e.g., microcrystallography); 4) they do not allow imaging of amyloids in complex systems under native and hydrated conditions (e.g., TEM); or 5) they require the presence of a substrate that may strongly influence the aggregation pathway of the growing fibrils (e.g., AFM) (26) . For example, direct investigation of the molecular basis of amyloid polymorphism of Aβ in AD brain tissue using ssNMR spectroscopy 6 was only possible by seeding brain--derived aggregates (seeds) to an excess of isotopically labeled monomeric proteins, yielding hundreds of milligrams of fibrils (27) (28) (29) . In TEM, samples are dried on the grid and stained with an electron--dense staining agent before imaging. Although this technique allows for rapid characterization of the structural morphology of the fibrils (30) , it may introduce several artifacts, such as flattening of the structure or incomplete stain embedding (31) . Cryo--EM can address these shortcomings because it does not require drying, staining or surface deposition. With this technique, the sample is frozen in a thin layer of vitreous ice, which allows fibrils to be imaged in their hydrated state. This method is increasingly used to investigate the structure of amyloid fibrils prepared in vitro or derived from different tissues (11, 13, 32) . However, the measurements are based on the weak contrast between fibrils and glassy ice and require a large number of images and advanced data analysis techniques to extract morphological information.
Herein, we describe the synthesis and application of gold nanoparticles (NPs) that efficiently label amyloid fibrils in a specific manner and in such a way so to unmask their polymorphism and morphological features. Our NPs combined with cryo--EM enable rapid screening and detailed characterization of amyloid morphological polymorphism under hydrated conditions Importantly, the resulting information cannot be directly observed using standard imaging techniques. One of the unique features of these NPs is that they efficiently label amyloid fibrils produced from a wide range of disease--associated recombinant proteins or synthetic peptides in vitro ((e.g. amyloid beta peptides, alpha--synuclein, TDP--43, Tau, immunoglobulin λ light chain and exon1 of the Huntingtin protein), despite the diversity of their amino acid sequence, secondary structure contents, and fibrillar morphology. Furthermore, our NPs efficiently label ex vivo disease--associated fibrils isolated from pathological aggregates derived from the brain and heart of patients that died from Alzheimer's disease and AL amyloidosis, respectively. Our results also show that brain and heart--derived amyloid fibrils isolated from pathological aggregates exhibit exceptional morphological homogeneity, in terms of their helical periodicity, in comparison to amyloid fibrils produced from recombinant proteins or peptide in vitro. These findings are consistent with and strongly support the emerging view that the physiologic milieu is a key determinant of amyloid fibril strains.
Results

MUS:OT NPs successfully label different polymorphs of amyloid fibrils.
Noble metal NPs have been previously used to study amyloid fibrils. Since 1971, gold NPs conjugated with a specific antibody have been successfully used to label amyloids (33) . This technique, called immunogold labeling, allows for the localization of amyloids in tissue sections and characterization of the sequence and structural properties of fibrils in solution (34, 35) . However, with this technique, NPs do not anchor directly on the fibrils but are located as far as 30 nm away due to the presence of the bulky antibody and linker. Therefore, the NPs used under these conditions cannot provide information about the structural or morphological features of amyloid fibrils, which renders this technique unsuitable for the characterization of fibril polymorphism (36) . There are also examples of amyloids being labeled using a nanomaterial without spacers, such as maghemite NPs (37, 38) , gold nanorods (39) or gold NPs (40, 41) . Due to their bulky size and the nonspecific nature of their interactions with amyloid fibrils, these nanomaterials are also unsuitable for unravelling morphological features and heterogeneity of fibrils.
To address these limitations, we sought to develop new tools that leverage the advantages offered by NPs, e.g., small size with significant electron density, to enable determining amyloid Positively charged and zwitterionic NPs were synthesized via modification of the method developed by Zheng et al. (42) , while anionic NPs were synthesized via a one--phase method, as described previously (42) and in the Supporting Information. The ligand shell composition was determined by 1 H--NMR spectroscopy after etching the gold core with iodine (43), while the size distribution of the Au core was determined using TEM ( Fig. 1A -B , Supporting Information, and Fig. S1 ).
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To achieve efficient labeling and visualization, we used gold NPs with a core diameter of ∼3 nm, as smaller particles are difficult to visualize in conventional cryo--EM and larger particles may result in a lower morphological accuracy and spatial localization of the fibril. To determine ligands with the best labelling efficiency, we first examined the interaction between Aβ 40 fibrils and the different types of gold NPs by coincubating fibrils with different NPs and then imaging them using cryo--EM. The Aβ 40 peptide is one of the constituents of amyloid plaques and one of the key defining pathological hallmarks of AD, together with the protein tau.
Previous studies have shown that Aβ 40 self--assembles and forms fibrils of different morphologies under different conditions (7, 11) , which makes it a good model system to study how our NPs can be used to characterize fibril polymorphs. Among all of the synthesized NPs, the mixture of OT and MUS ligands on the gold surface was the most efficient in labeling Aβ 40 fibrils, as the other NPs tested either did not attach efficiently to the fibril surface or formed large fibril--NP aggregates (Supporting Information, Fig.  S2 ). We observed that both types of MUS:OT NPs showed similar amyloid labeling efficiency despite the small difference in the hydrophobic ligand ratio (Fig. 2 ). Higher ratios of OT in the ligand shell often resulted in reduced NP solubility under the buffer conditions used in this study. These observations combined with molecular dynamics simulations studies (Supporting information) lead us to hypothesize that labeling efficiency depends on the hydrophobic contacts between the NPs and the amyloid fibrils.
We also examined the influence of our nanomaterial on the secondary structure and fibril morphology of Aβ 40 by coincubating Aβ 40 with NPs during the aggregation process and on the mature fibrils obtained at the end of the aggregation reaction. As shown in Fig. S3 , the spectra of the fibrils incubated with MUS:OT A NPs (both during the aggregation process and of mature fibrils) are comparable to those of the control sample (i.e., CD spectra of fibrils incubated in the absence of NPs) and did not change significantly over time. This result is a strong indication that the presence of NPs does not modify the secondary structure of the amyloid fibrils and that the possible influence on the fibril structure upon decoration with NPs is minimal.
To illustrate the advantage of using our NPs, we imaged fibrils derived from the second repeat region of tau via negative staining TEM, cryo--EM and cryo--EM after coincubation with NPs and 9 fibrils. Fig.  1C can be used as a comparison between imaging fibrils with the use of all three techniques. As shown in Fig  1C, NPs facilitate the visualization of the amyloid edges in cryo--EM while retaining the main advantage of cryo--EM relative to that of negative stain TEM, i.e., eliminating the need for drying.
To determine whether our NPs could decorate fibrils that do not present clear twisted morphologies, we incubated NPs with transactive response DNA--binding protein 43 (TDP-- 43) fibrils, which is implicated in several neurodegenerative conditions including amyotrophic lateral sclerosis (ALS), subsets of frontotemporal dementia (FTLD--TDP) and AD (44) . We were able to obtain uniform decoration with MUS:OT A NPs across the entirety of the fibrils ( edges are easily discerned from the background, allowing for immediate determination of the type of morphological polymorph. We observe that Aβ 40 fibrils exist predominantly as two classes of polymorphs: two--and three--folded helical symmetries around the longitudinal axis ( Fig. 2A -C) . The NP labeling facilitated the measurement of the crossover length distribution of the two--fold twisted fibril population (Fig. 2D) , facilitating image analysis and quantification of the fibrils' morphological parameters. Cryo--EM technique projects three--dimensional objects as a two--dimensional image. Two--fold symmetric images can be generated by the projection of twisted ribbons. More complex geometries may have the appearance of a three-fold symmetry that stems either from a twisted ribbon, a triangular cross--section, or helical ribbons (23) . In this paper, we refer to the apparent image symmetry, not to the effective object symmetry (Fig. S4) .
To investigate the effect of the aggregation conditions on the polymorphic population, we prepared Aβ 40 fibrils using two different procedures: with and without agitation. The high affinity of the NPs to the fibril edges allows for rapid determination of the differences in the structural polymorph distribution between these two conditions. We observe that fibrils formed under quiescent conditions are longer and present a twisted helical symmetry, while those prepared under agitation are shorter and resemble straight ribbons devoid of any visible twist ( Fig. 2E ).
Tau is a natively unfolded protein, but under pathological conditions, it undergoes conformational changes that render the protein more prone to aggregation into paired helical filaments (PHFs). PHFs are the main component of the intracellular neurofibrillary tangles in the brains of AD patients (45) . Tau's ability to adopt β--sheet conformations, necessary for amyloid aggregation, relies mainly on small peptide motifs located in the second, third and fourth microtubule binding domains (MTBDs) of tau (46) . To determine if the MUS:OT NPs could bind and label fibrils derived from other amyloid--forming peptides, we incubated them with fibril preparations of the MTBD--derived peptide (repeat unit R2), which exhibits a high propensity to self--assemble into a wide variety of fibril morphological polymorphs (47, 48) .
MUS:OT A NPs adsorbed selectively to the different tau peptide fibril polymorphic typeswide fibrils with a clear twist were densely decorated, while smooth and thin fibrils were not decorated by the NPs (Fig. 2F ). This was observed even after prolonged periods of coincubation ( Fig.  S5 ) or with higher ratios of NPs to fibrils (Fig.  2G) , with free and unbound NPs visible in the glassy ice, indicating that the different labeling patterns correlate with the different fibril surface properties rather than incubation conditions. Furthermore, within the labeled amyloid fraction, many polymorphs could be differentiated: straight and clear three-fold symmetric structures (Fig. 2H ) and a whole range of two--fold twisted fibrils with different periodicity (Fig. 2I) . These diverse fibril polymorphs could not be detected by negative staining or easily visualized by standard cryo--EM. As in the case of Aβ 40 , our NP--based procedure provided a rapid tool to establish the morphological diversity of the tau peptide fibrils.
To demonstrate that the NPs represent versatile cryo--EM markers for other amyloid--forming proteins, we incubated them with fibrils derived from different amyloidogenic proteins with different amino acid sequences that also form polymorphic fibrillar aggregates. To this end, we prepared fibrils from several proteins that have been linked to the pathogenesis of Alzheimer's (tau) Parkinson's (α--synuclein and C--terminally truncated α--synuclein (1--120)) and Huntington's disease (mutant exon 1 of the huntingtin protein (residues 2 to 90), with 43 glutamines in the polyQ region - Httex1 43Q). Fig.  3 demonstrates that the NPs successfully label the fibrils produced from all these proteins, despite their sequence diversity and heterogeneous morphologies. Interestingly, compared to the Aβ 40 and R2 fibrils, onto which the NPs bind to the fibril edges, both the tau and Httex1 43Q fibrils are decorated on the whole fibril surface.
MUS:OT NPs successfully label minute amounts of ex vivo samples and allow determination of polymorph distribution in human--derived samples.
Finally, we sought to determine whether our NPs could be effective as a contrast agent in cryo--EM for human--derived samples. To achieve this goal, we used native tau PHFs isolated from the brain affected by AD and amyloid fibrils of an immunoglobulin λ light chain that were purified from the heart of a patient suffering from AL amyloidosis. We incubated both ex vivo fibril preparations with MUS:OT A NPs.
The cryo--EM images of AL amyloids show rather uniform and densely decorated fibrils with the crossovers clearly visible owing to the presence of the NPs, a feature that is not as evident in the normal cryo--EM and negative stain TEM images ( Fig. 4A --C).
Similar data was obtained from enriched PHF samples from an AD postmortem brain. It is important to note that this sample still contained other nonamyloidogenic elements such as cell debris, proteins and other biological contaminants. The cryo--EM images indeed revealed the presence of many biological structures that were entangled with MUS:OT A gold NPs (Fig.   S6 ). However, the PHFs were readily distinguishable from contaminants, which was due to the contrast provided by the NPs highlighting the characteristic fibrillar shape of a rather uniform double twisted morphology. (Fig. 4D -E) . Recent advances in cryo--EM have enabled previously inaccessible insight into the structural properties of amyloid fibrils derived from recombinant and synthetic proteins of different sizes and even fibrils isolated from postmortem human tissues (11, 13, 52) . One key step in the process of solving the structures of amyloids by cryo--EM involves the screening of sample conditions to identify conditions that reduce the structural and morphological diversity of the fibrils and/or favor the formation of specific populations of fibril structures. Therefore, the polymorphic diversity within a sample is not usually accounted for or reflected in the final structure. To address this limitation and allow for comprehensive and rapid analysis of fibril polymorphism, we propose the use of gold NPs as a potent tool to label and characterize fibril morphologies and polymorphism under hydrated conditions. Gold NPs have an electron-dense core that affords strong contrast under TEM and does not require any additional staining and/or processing to enhance the contrast. As such, we have developed an NP--based cryo--EM technique to simplify the analysis of fibril polymorphism derived from samples of different origin. The MUS:OT NPs exhibit a high propensity to attach to the edges of fibrils composed of various amyloid proteins, enabling rapid characterization of their polymorphic distribution in minute samples of increasing complexity. The improved contrast provided by the NP decoration also allows for quantitative image analysis, including the measurement of periodicity characteristics such as width and length. All of this can be done without extensive data collection and treatment. In a typical experiment, 3 microliters of fibril solution were sufficient to prepare a sample; hence, this technique allows for the labeling and characterization of fibrils in samples with low amounts of fibrils, e.g., purified fibrils isolated from postmortem tissues or biological fluids (e.g., plasma and cerebrospinal fluid, CSF).
The MUS:OT NPs appear to bind with different affinities to different fibril polymorphs. For example, in the case of the fibrils made of tau peptide fragments, we observed a different labeling pattern between twisted fibrils that were highly decorated and what appeared to be thin fibrils that were not decorated at all. These differences in labeling morphologically polymorphic species may indicate differences in surface properties and may be used in the future to separate specific polymorphs from a heterogeneous population using an NP--based purification strategy. Another mode of labeling was observed on the full--length recombinant tau, TDP 43 and Httex1 43Q fibrils, which were densely decorated along the whole surface, not only on the edges. This finding may be explained by the greater variability of exposed surfaces, which results in more adsorption sites for the NPs.
The analysis of recombinant and synthetic samples showed a wide range of structural polymorphs with variability in periodicity length and labeling efficacy. In Fig. 5C , we show an analysis that correlates the periodicity length and width for synthetic Aβ 40 and recombinant tau peptides. The results are in agreement with the theory proposed by De los Rios (53) , which assumes that the periodicity of the fibril depends on the number of protofilaments constituting the fibril. The correlation shown in Fig. 5C suggests a linear dependence of these two parameters for the amyloids aggregated in vitro. In contrast, the ex vivo samples analyzed here were composed of a rather homogenous fibril population, suggesting uniform protofibril number per mature amyloid. We observed a narrow distribution of the periodicity width and length in the AL and PHF amyloids, which showed remarkably conserved periodicity characteristics. This uniformness of the ex vivo fibrils contrasts with the amyloids derived from recombinant or synthetic proteins in cell--free systems, which revealed great polydispersity in terms of periodicity width and length. Our findings suggest that the mechanisms of amyloid formation in vitro may vary greatly from those occurring in vivo. An alternative explanation could be that amyloid formation in vivo is guided by complex interactions and conditions that are defined by the cellular or extracellular milieu (16) and are difficult to replicate in cell--free systems. The ex vivo fibril homogeneity could also be explained by the fact that each ex vivo sample was derived from a separate patient.
Previously published analysis of AL fibrils obtained from two patients showed that the fibrils formed two morphologically distinct aggregates that differed in width and periodicity length (30) . Moreover, the two human--derived samples also presented distinct fibrillar characteristics, where one type of fibril revealed a width of approximately 11 nm and a pitch length distance of approximately 163 nm. The dimensions of these fibrils partially correspond to those of the AL fibrils that we analyzed. Our sample, however, revealed fibrils that were slightly wider and had a shorter pitch length. These differences may stem from the different methods used to obtain the micrographs, i.e., negative stain TEM and cryo--EM. It may also be caused by the fact that each patient develops fibrils of a different morphology.
Herein, we show that MUS:OT NPs efficiently label amyloid fibrils and allow for rapid profiling of their polymorphism. This labeling can be used in cryo--EM enabling direct detection and characterization of amyloid fibrils from ex vivo samples, with an image quality comparable to that achieved for amyloids obtained in vitro. Our findings also reveal striking morphological differences between the in vitro and ex vivo amyloid fibrils, consistent with emerging data pointing to the physiological milieu as the key determinant of amyloid fibril strains. Our method does not require elaborate enrichment, seeding, or any other form of extensive sample processing: the native fibril is directly observable in its solvated state. We believe that our NPs can be used as a complementary tool in studying the polymorphic distribution of 
Materials and Methods
All compounds used in this study are detailed in the Materials and Methods section of the Supporting Information. Experimental procedures for ligand and NPs synthesis and characterization, amyloid fibrils preparation and incubation with NPs, microscopy measurement, circular dichroism and image analysis are described in Supporting Information. 
